These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 23846135)
1. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition. Martinez-Raga J; Szerman N; Knecht C; de Alvaro R Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135 [TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Fatseas M; Debrabant R; Auriacombe M Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385 [TBL] [Abstract][Full Text] [Related]
5. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission. Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240 [TBL] [Abstract][Full Text] [Related]
6. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders. Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA; Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249 [TBL] [Abstract][Full Text] [Related]
7. [Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions]. Matthys F; Joostens P; van den Brink W; Sabbe B Ned Tijdschr Geneeskd; 2013; 157(24):A6025. PubMed ID: 23759179 [TBL] [Abstract][Full Text] [Related]
8. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. Upadhyaya HP J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378 [TBL] [Abstract][Full Text] [Related]
9. Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions. Knecht C; de Alvaro R; Martinez-Raga J; Balanza-Martinez V Int J Adolesc Med Health; 2015 May; 27(2):163-75. PubMed ID: 25411986 [TBL] [Abstract][Full Text] [Related]
10. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Haavik J; Halmøy A; Lundervold AJ; Fasmer OB Expert Rev Neurother; 2010 Oct; 10(10):1569-80. PubMed ID: 20925472 [TBL] [Abstract][Full Text] [Related]
11. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor? Kousha M; Shahrivar Z; Alaghband-Rad J J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397 [TBL] [Abstract][Full Text] [Related]
12. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity. Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575 [TBL] [Abstract][Full Text] [Related]
13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
14. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853 [TBL] [Abstract][Full Text] [Related]
15. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic. Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330 [TBL] [Abstract][Full Text] [Related]
16. Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective. Frodl T J Atten Disord; 2010 Sep; 14(2):109-20. PubMed ID: 20495160 [TBL] [Abstract][Full Text] [Related]
17. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. Levin FR J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376 [TBL] [Abstract][Full Text] [Related]
18. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Wilens TE Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998 [TBL] [Abstract][Full Text] [Related]
19. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study. Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365 [TBL] [Abstract][Full Text] [Related]
20. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]